Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0EW4L
|
|||
| Former ID |
DAP000867
|
|||
| Drug Name |
Abatacept
|
|||
| Synonyms |
Orencia (TN)
Click to Show/Hide
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Approved | [1], [2], [3] | |
| Therapeutic Class |
Antirheumatic Agents
|
|||
| Company |
Bristol-Myers Squibb
|
|||
| ADReCS Drug ID | BADD_D00012 | |||
| SuperDrug ATC ID |
L04AA24
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6891). | |||
| REF 2 | Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54. | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | Selective modulation of T-cell co-stimulation: a novel mode of action for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2009 May-Jun;27(3):510-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.